Fidelity Investments’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,961
| Closed | -$1.83M | – | 4398 |
|
|
2019
Q3 | $1.83M | Hold |
14,961
| – | – | ﹤0.01% | 2287 |
|
|
2019
Q2 | $4.47M | Sell |
14,961
-3,388
| -18% | -$1.01M | ﹤0.01% | 2125 |
|
|
2019
Q1 | $8.26M | Sell |
18,349
-1,695
| -8% | -$763K | ﹤0.01% | 1928 |
|
|
2018
Q4 | $9.16M | Buy |
20,044
+110
| +0.6% | +$50.3K | ﹤0.01% | 1832 |
|
|
2018
Q3 | $18.1M | Buy |
19,934
+556
| +3% | +$505K | ﹤0.01% | 1717 |
|
|
2018
Q2 | $11.4M | Buy |
19,378
+154
| +0.8% | +$90.4K | ﹤0.01% | 1910 |
|
|
2018
Q1 | $12.5M | Buy |
19,224
+15,483
| +414% | +$10.1M | ﹤0.01% | 1896 |
|
|
2017
Q4 | $1.37M | Hold |
3,741
| – | – | ﹤0.01% | 2411 |
|
|
2017
Q3 | $1.15M | Hold |
3,741
| – | – | ﹤0.01% | 2403 |
|
|
2017
Q2 | $1.79M | Hold |
3,741
| – | – | ﹤0.01% | 2359 |
|
|
2017
Q1 | $4.66M | Hold |
3,741
| – | – | ﹤0.01% | 2187 |
|
|
2016
Q4 | $1.51M | Hold |
3,741
| – | – | ﹤0.01% | 2412 |
|
|
2016
Q3 | $1.56M | Hold |
3,741
| – | – | ﹤0.01% | 2406 |
|
|
2016
Q2 | $1.75M | Hold |
3,741
| – | – | ﹤0.01% | 2406 |
|
|
2016
Q1 | $1.93M | Hold |
3,741
| – | – | ﹤0.01% | 2394 |
|
|
2015
Q4 | $2.94M | Hold |
3,741
| – | – | ﹤0.01% | 2337 |
|
|
2015
Q3 | $5.13M | Hold |
3,741
| – | – | ﹤0.01% | 2163 |
|
|
2015
Q2 | $7.51M | Buy |
+3,741
| New | +$7.51M | ﹤0.01% | 2127 |
|